HON vs MIRA · P/E 36, rev $9.72B vs $41.1M cap
Honeywell International Inc (HON) versus MIRA Pharmaceuticals, Inc. Common Stock (MIRA) — a side-by-side from cached financials, not a winner call.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal M. Kapur.
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a drug manufacturers - general company listed on NASDAQ.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
MIRA does not have a complete income-statement cache yet.
HON currently screens at market cap $144.86B and trailing P/E 36.5. MIRA currently screens at market cap $41.1M.
Not investment advice. Open the HON and MIRA stock pages for the full models.
Not investment advice.